LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
Clinical trials for LOCALLY ADVANCED OR METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill plus immunotherapy targets Hard-to-Treat cancers
Disease control Not yet recruitingThis study tests a combination of two drugs—CVL237 tablets and serplulimab injection—in people with advanced solid tumors that have lost or have low levels of a protein called PTEN. The trial aims to find the safest dose and see if the combo can shrink tumors or delay their growt…
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE2 • Sponsor: Convalife (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New drug cocktail targets Hard-to-Treat cancers
Disease control Not yet recruitingThis Phase 2 study tests two oral drugs, GH21 and D-1553, in 120 adults with advanced solid tumors that have a specific mutation called KRASG12C. Participants have already tried other treatments without success. The goal is to see if the combination can shrink tumors and control …
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE2 • Sponsor: Suzhou Genhouse Bio Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC